molnupiravir

Covid-19 test at KSR Railway station in Bengaluru

Early Signs of COVID Cases Plateauing, but Situation Needs To Be Observed: Govt

Eleven states have over 50,000 active COVID cases, which...

Weekend curfew following the rise in COVID-19 cases in Delhi

‘Urgent Need for Evidence-based COVID Response’: Experts Write to Centre, States

The Wire Staff 14/01/2022

Healthcare workers, medical researchers and public health experts have...

Screenshot 2020-09-07 at 2.19.04 PM

ICMR Chief Bhargava Takes Strong Stand Against Molnupiravir for COVID

Banjot Kaur 12/01/2022

Balram Bhargava has enumerated six reasons for the ICMR’s...

FILE PHOTO: An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc

Molnupiravir Not Included in India’s COVID-19 Clinical Management Protocol

The experts of the task force cited safety concerns...

An employee at Serum Institute of India removes vials of AstraZeneca's Covishield from a visual inspection machine inside a lab. Photo: Reuters/Francis Mascarenhas

DCGI Approved a Drug and Two Vaccines. Officials Have Now Sidelined Them.

Banjot Kaur 06/01/2022

It seems the DCGI's three most recent approvals, which...

FILE PHOTO: A man wearing a Santa Claus costume helps an auto rickshaw driver to wear a protective face mask, in Ahmedabad

COVID-19: Govt Panel Recommends EUA for Covovax, Corbevax and Molnupiravir

Payal Banerjee 28/12/2021

So far six COVID-19 vaccines have received emergency-use authorisation...

Pfizer Confirms COVID Pill’s Results, Potency Versus Omicron

Matthew Perrone 14/12/2021

Pfizer is also studying its pill in lower-risk adults...